Evidence map›Paper›PMID 33145104›Full record

ArticleInternational journal of hypertension2020

Polymorphism of MTHFR C677T Gene and the Associations with the Severity of Essential Hypertension in Northern Chinese Population.

Junli Song, Jie Hou, Qiang Zhao, Xuezhi Liu, Qian Guo, Donghong Yin, Yan Song, Xiaoxia Li, Shuyun Wang, Xinchun Wang and 1 more

Abstract read
In one paragraph

Article in International journal of hypertension, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. [Association betweenZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Junli SongDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Jie HouDepartment of Pharmacy, Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi 030001, China.
Qiang ZhaoDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Xuezhi LiuDepartment of Hospital Infection Control, Linfen Central Hospital, Linfen, Shanxi 041000, China.
Qian GuoDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Donghong YinDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Yan SongDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Xiaoxia LiDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Shuyun WangDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Xinchun WangDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Jinju DuanDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China.ORCID https://orcid.org/0000-0002-4310-1333

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMethylenetetrahydrofolate reductase (MTHFR) is a key enzyme of homocysteine metabolism and is closely related to the occurrence of hypertension. The aim of this study was to investigate the polymorphism of the (MTHFR) C677T and the factors influencing the severity of hypertension.

resultsThe frequencies of CC, CT, and TT genotypes were 19.5%, 49.95%, and 30.46%, respectively. The allelic frequency of mutant

conclusionMTHFR gene, smoking, family history of hypertension, Hcy, and triglycerides could be important genetic and high-risk factors of the development of severe hypertension in northern Chinese. These factors will contribute to the identification of high-risk populations of hypertension and facilitate the development of hypertension control strategies.

Identifiers

PMID33145104
PMCPMC7596525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.